NO984937L - Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling - Google Patents

Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling

Info

Publication number
NO984937L
NO984937L NO984937A NO984937A NO984937L NO 984937 L NO984937 L NO 984937L NO 984937 A NO984937 A NO 984937A NO 984937 A NO984937 A NO 984937A NO 984937 L NO984937 L NO 984937L
Authority
NO
Norway
Prior art keywords
antigen
immunosuppressive therapy
new peptides
peptides suitable
specific immunosuppressive
Prior art date
Application number
NO984937A
Other languages
English (en)
Norwegian (no)
Other versions
NO984937D0 (no
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO984937D0 publication Critical patent/NO984937D0/no
Publication of NO984937L publication Critical patent/NO984937L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO984937A 1996-04-24 1998-10-23 Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling NO984937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201106 1996-04-24
PCT/EP1997/002051 WO1997040068A1 (en) 1996-04-24 1997-04-22 Novel peptides suitable for use in antigen specific immunosuppressive therapy

Publications (2)

Publication Number Publication Date
NO984937D0 NO984937D0 (no) 1998-10-23
NO984937L true NO984937L (no) 1998-12-01

Family

ID=8223915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984937A NO984937L (no) 1996-04-24 1998-10-23 Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling

Country Status (20)

Country Link
US (1) US6184204B1 (zh)
EP (1) EP0920451A1 (zh)
JP (1) JP2000510106A (zh)
KR (1) KR20000010561A (zh)
CN (1) CN1216551A (zh)
AR (1) AR006813A1 (zh)
AU (1) AU719481B2 (zh)
BR (1) BR9708744A (zh)
CA (1) CA2251680A1 (zh)
CZ (1) CZ340698A3 (zh)
HU (1) HUP9901375A3 (zh)
IL (1) IL120561A0 (zh)
NO (1) NO984937L (zh)
NZ (1) NZ332427A (zh)
PL (1) PL329618A1 (zh)
RU (1) RU2199548C2 (zh)
TR (1) TR199802135T2 (zh)
TW (1) TW575583B (zh)
WO (1) WO1997040068A1 (zh)
ZA (1) ZA973071B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2001286A3 (en) * 1998-07-23 2001-08-15 Akzo Nobel Nv Use of isolated DNA or RNA molecule, viral vector and process for preparing thereof
WO2001029081A1 (en) * 1999-10-18 2001-04-26 Akzo Nobel N.V. Modified peptides and peptidomimetics for use in immunotherapy
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
ES2281434T3 (es) 2000-08-14 2007-10-01 Ortho-Mcneil Pharmaceutical, Inc. Pirazoles sustituidos.
US7002985B2 (en) * 2001-01-16 2006-02-21 Motorola, Inc. Method and apparatus for organizing and scheduling multimedia data transfers over a wireless channel
ES2534752T3 (es) * 2004-12-07 2015-04-27 Toray Industries, Inc. Nuevo péptido antigénico contra el cáncer y utilización del mismo
DE602006019205D1 (de) * 2005-02-28 2011-02-10 Bio Y As Monoklonale ykl-40-antikörper
FR2908654B1 (fr) 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
RS53782B1 (en) * 2008-10-01 2015-06-30 Immatics Biotechnologies Gmbh TUMOR-ASSOCIATED PEPTIDES PREPARED AND ANTI-CHANGE RESPONSE FOR GLIOBLASTOMA (GBM) AND OTHER CANCER TREATMENTS
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
CA2768246A1 (en) 2009-06-11 2010-12-16 The University Of Guelph Serine rich peptides having antioxidative stress properties
CA2779161A1 (en) 2009-10-28 2011-05-05 University Of Manitoba Yellow pea seed protein-derived peptides
CA2801237A1 (en) 2010-05-31 2011-12-08 London Health Sciences Centre Research Inc. Rhamm binding peptides
WO2018129261A1 (en) 2017-01-05 2018-07-12 Brown University Methods and compositions relating to anti-chi3l1 antibody reagents
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
WO1997040068A1 (en) 1997-10-30
NO984937D0 (no) 1998-10-23
JP2000510106A (ja) 2000-08-08
HUP9901375A2 (hu) 1999-08-30
US6184204B1 (en) 2001-02-06
RU2199548C2 (ru) 2003-02-27
IL120561A0 (en) 1997-07-13
AU2768597A (en) 1997-11-12
HUP9901375A3 (en) 2000-10-30
TW575583B (en) 2004-02-11
NZ332427A (en) 2000-03-27
EP0920451A1 (en) 1999-06-09
BR9708744A (pt) 1999-08-03
TR199802135T2 (xx) 1999-01-18
AR006813A1 (es) 1999-09-29
AU719481B2 (en) 2000-05-11
CN1216551A (zh) 1999-05-12
CA2251680A1 (en) 1997-10-30
KR20000010561A (ko) 2000-02-15
PL329618A1 (en) 1999-03-29
ZA973071B (en) 1998-08-05
CZ340698A3 (cs) 1999-02-17

Similar Documents

Publication Publication Date Title
DE69717192D1 (de) Von einem Patienten tragbare Energieabgabevorrichtung
DE69601413D1 (de) Brennstoffzuführvorrichtung
DE69709885D1 (de) Speichersystem und einrichtung
NO991903D0 (no) Naftyridinderivater
DE69702518D1 (de) Kraftstoffabgabevorrichtung
NO984937L (no) Nye peptider egnet for anvendelse i antigenspesifikk immunundertrukkende behandling
DE59706202D1 (de) Stromverteilungsvorrichtung
DE69713691D1 (de) Mobileinheit und Mobileinheit-Unterstützungssystem
FI101738B1 (fi) Ruiskutusventtiilijärjestely
GB9713399D0 (en) Portable device and concentrator therefor
DK0770132T3 (da) Nye streptograminer
DE69725663D1 (de) Abrechnungsverfahren und System
DK0931436T3 (da) Energifordelingssystem
IT1282692B1 (it) Citochine modificate per l'uso in terapia
BR9702084A (pt) Antagonista de peptídeo de mitogénese e motogénese celulares e o uso terapeutico dos mesmos
FI970744A0 (fi) Uusia immuuniehkäiseviä peptidejä
NO982077D0 (no) Energifordelingssystem i skip
DE69728993D1 (de) Hochspannungssystem
KR970060499U (ko) 미용의자 높낮이 조절장치
KR970056712U (ko) 조정식 미용 의자
KR980005555U (ko) 휴대용 접지장치
EA199900378A1 (ru) Устройство для распределения воды в градирне
FR2746557B3 (fr) Generateur solaire portable
DE59710845D1 (de) Schwenkbare Trageinrichtung
SE9602287D0 (sv) Novel protein and methods for its use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application